News
- 2021.08.12 OTHER Appointment of Shinya Yamanaka, Representative Director of CiRA Foundation, as the chair the Scientific Advisory Board of Orizuru Therapeutics Inc.
- 2021.08.05 RESEARCHES Free provision of iPS cells made from 6 COVID-19 convalescent patients
-
2021.06.01
RESEARCHES
First shipment of the iPS cell stock to an overseas partner
-
2021.05.19
EVENT&SEMINARS
Report : 1st Anniversary Activity Video Event
- 2021.05.19 RESEARCHES Provision of HLA-homozygous iPS cellｓ to Novo Nordisk
- 2021.05.18 RESEARCHES Platelets derived using the CiRA Foundation iPS Cell Stock enter an industry-led clinical trial
- 2021.05.10 RESEARCHES CiRA Foundation's First International Provision of HLA-homozygous iPS cell stock to CHA University in Korea
-
2021.04.09
EVENT&SEMINARS
First Anniversary of the CiRA Foundation: Beginning of the fiscal year meeting to renew our spirits
- 2021.03.26 RESEARCHES HLA-genome-edited iPS cell production contracted by Vision Care Inc.
- 2021.03.25 RESEARCHES CiRA Foundation is now accepting applications for the free provision of iPS cells made from COVID-19 convalescent patients